CORDIS ENTERING ELECTROPHYSIOLOGY ARENA VIA WEBSTER LABS BUY
This article was originally published in The Gray Sheet
Executive SummaryCORDIS ENTERING ELECTROPHYSIOLOGY ARENA VIA WEBSTER LABS BUY, under a definitive agreement announced Jan. 21. The stock-for- stock transaction, estimated to be worth approximately $85 mil., "is structured as a tax-free reorganization of Webster and is expected to be accounted for as a pooling of interests," Cordis said. The deal is expected to close in the first calendar quarter of 1994.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.